Novozymes (NVZMY)
(Delayed Data from OTC)
$65.19 USD
+0.20 (0.31%)
Updated Aug 1, 2025 03:59 PM ET
1-Strong Buy of 5 1
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVZMY 65.19 +0.20(0.31%)
Will NVZMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVZMY
Has Harmony Gold (HMY) Outpaced Other Basic Materials Stocks This Year?
Novozymes (NVZMY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Basic Materials Stocks Lagging Iamgold (IAG) This Year?
Is Novozymes (NVZMY) Stock Outpacing Its Basic Materials Peers This Year?
Best Income Stocks to Buy for May 14th
Other News for NVZMY
Novonesis (NVZMY) Target Price Upgraded by Berenberg Analyst | NVZMY Stock News
Novonesis price target raised to DKK 530 from DKK 510 at Berenberg
Novonesis price target raised by DKK 20 at Berenberg
Jefferies Sticks to Their Buy Rating for Novonesis (0Q4U)
Kepler Capital Remains a Hold on Novonesis (0Q4U)